Medtronic Inc. (MDT): Today's Featured Health Care Straggler

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Medtronic ( MDT) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.1%. By the end of trading, Medtronic fell 52 cents (-1.1%) to $47.20 on average volume. Throughout the day, 4.4 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.4 million shares. The stock ranged in price between $46.91-$47.69 after having opened the day at $47.50 as compared to the previous trading day's close of $47.72. Other companies within the Health Care sector that declined today were: Redhill Biopharma ( RDHL), down 11.9%, Immunogen ( IMGN), down 9.7%, MannKind Corporation ( MNKD), down 8.4%, and Iridex Corporation ( IRIX), down 7.7%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $47.89 billion and is part of the health services industry. The company has a P/E ratio of 14.4, below the S&P 500 P/E ratio of 17.7. Shares are up 16.3% year to date as of the close of trading on Thursday. Currently there are nine analysts that rate Medtronic a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front, Biocryst Pharmaceuticals ( BCRX), up 13.9%, American Shared Hospital ( AMS), up 9.6%, KYTHERA Biopharmaceuticals ( KYTH), up 9.3%, and Urologix ( ULGX), up 7.9%, were all gainers within the health care sector with Biogen Idec ( BIIB) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

The 5 Best Dividend Aristocrats For 2018

The 5 Best Dividend Aristocrats For 2018

Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms

Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms

These Stocks Are Showing Reversal Patterns

These Stocks Are Showing Reversal Patterns